Search

everythinglearnresearchcommunity

for

Search:↓

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

PLD is an effective and safer alternative for treating breast cancer.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

New treatments for lupus show promise, but more research is needed, especially for children.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

New genes linked to ichthyosis were found, but there's still no cure; treatment options are improving.

Effective symptom management in IBD improves quality of life and prevents complications.

Thermography matched the patient's pain levels in a shingles case and might help diagnose shingles without a rash.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Nineteenth-century British drama closely reflected the era's societal values and concerns.

Biologics for severe asthma have known side effects, but some new risks need more study.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

COVID-19 can cause different skin issues, including rashes and hair loss.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Transplant patients often get skin problems, with treatments varying by condition.